Salbutamol with ipratropium bromide (Duolin) nebuliser: Supply issue resolved
A manufacturing delay has caused a supply constraint for Duolin salbutamol with ipratropium nebuliser solution (Pharmacode 2039281).
24 July 2024
Stock of Duolin nebuliser solution (Pharmacode: 2039281) is available from the supplier again. It may take another 2 or 3 weeks to reach pharmacies around the country.
Affected product
Rex Medical, the supplier, advised that the manufacturing site for Duolin nebuliser solution was temporarily halted production to facilitate annual validation. Rex Medical moved production of this medicine to a second registered site. This caused a delay in resupply.
- Chemical: Salbutamol with ipratropium bromide
- Presentation: Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 2.5 ml ampoule - Up to 20 neb available on a PSO
- Brand: Duolin
- Pharmacode: 2039281
Schedule listings for Duolin(external link)
Alternative treatment
From 4 June 2024 the following will be listed in the Community Schedule. It will be listed from 1 July 2024 in the HML. Note the pack size is the same as the registered product.
- Chemical: Salbutamol with ipratropium bromide
- Presentation: Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 2.5 ml ampoule
- Brand: Duolin Cipla
- Pack Size: 20
- Subsidy (and price): $11.04 (ex-man., ex. GST)
- Pharmacode: 2680807
Resupplied by 24 July 2024
Rex Medical advises that the registered product, Duolin, is back in stock.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)